Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
Clinical trial NCT00660335 · COMPLETED
Trial details
- NCT number
- NCT00660335
- Sponsor
- Repligen Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-10-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.